Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04499053
Title Durvalumab in Combination With Chemotherapy in Virus-infected Patients With Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Georgetown University
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Durvalumab + Paclitaxel

Carboplatin + Durvalumab + Nab-paclitaxel

Cisplatin + Durvalumab + Pemetrexed Disodium

Carboplatin + Durvalumab + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington District of Columbia 20007 United States Details
Medstar Washington Hospital Center Recruiting Washington District of Columbia 20010 United States Details
Harry and Jeannette Weinberg Cancer Institute at Franklin Square Recruiting Baltimore Maryland 21237 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field